The prevalence of nonalcoholic steatohepatitis is greater in morbidly obese men compared to women

被引:49
作者
Arun, Janani
Clements, Ronald H.
Lazenby, Audrey J.
Leeth, Ruth R.
Abrams, Gary A.
机构
[1] Univ Alabama Birmingham, UAB Liver Ctr, Dept Med, Div Gastroenterol & Hepatol, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Dept Surg, Div GI Surg, Birmingham, AL 35294 USA
[3] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA
关键词
hepatic steatosis; metabolic syndrome; bariatric surgery; morbid obesity; type; 2; diabetes;
D O I
10.1381/096089206778663715
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Nonalcoholic steatohepatitis (NASH) is a form of liver injury that is common in morbidly obese subjects. It has been shown that gender differences exist in the spectrum of nonalcoholic fatty liver disease (NAFLD). The focus of this study was to further characterize these gender differences based on ATP III criteria used to diagnose the metabolic syndrome (MS). Methods: We retrospectively assessed NAFLD 58 men and 307 women who underwent gastric bypass, for the presence of NASH, MS, and positive predictors of NASH. Results: There was no statistical difference in age, gender, or the presence of diabetes. The prevalence of NASH in men and women was 60.3% and 30.9%, respectively (P<0.001). Multivariate logistic analysis showed an association of male gender with NASH (2.7; 95% Cl, 1.3-5.6, P=0.006) as well as age, AST, and diabetes. MS was diagnosed in 91.4% and 76.2% of men and women (P=0.008), and men tended to have more criteria for MS compared to women. The only positive predictor of MS that was statistically significant between genders was high triglycerides (P=0.003). Controlling for BMI and excess body weight produced similar results. Conclusions: Gender differences do exist within NAFLD and MS, that may be associated with free fatty acid flow to the liver.
引用
收藏
页码:1351 / 1358
页数:8
相关论文
共 45 条
[1]   Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease [J].
Abrams, GA ;
Kunde, SS ;
Lazenby, AJ ;
Clements, RH .
HEPATOLOGY, 2004, 40 (02) :475-483
[2]  
ANDERSEN T, 1984, INT J OBESITY, V8, P97
[3]   Non-alcoholic fatty liver syndrome: A hepatic consequence of common metabolic diseases [J].
Angelico, F ;
Del Ben, M ;
Conti, R ;
Francioso, S ;
Feole, K ;
Maccioni, D ;
Antonini, TM ;
Alessandri, C .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2003, 18 (05) :588-594
[4]   Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis [J].
Angulo, P ;
Keach, JC ;
Batts, KP ;
Lindor, KD .
HEPATOLOGY, 1999, 30 (06) :1356-1362
[5]   NONALCOHOLIC STEATOHEPATITIS - AN EXPANDED CLINICAL ENTITY [J].
BACON, BR ;
FARAHVASH, MJ ;
JANNEY, CG ;
NEUSCHWANDERTETRI, BA .
GASTROENTEROLOGY, 1994, 107 (04) :1103-1109
[6]   Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity [J].
Browning, JD ;
Szczepaniak, LS ;
Dobbins, R ;
Nuremberg, P ;
Horton, JD ;
Cohen, JC ;
Grundy, SM ;
Hobbs, HH .
HEPATOLOGY, 2004, 40 (06) :1387-1395
[7]   Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions [J].
Brunt, EM ;
Janney, CG ;
Di Bisceglie, AM ;
Neuschwander-Tetri, BA ;
Bacon, BR .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (09) :2467-2474
[8]  
CLAIN DJ, 1987, GASTROENTEROL CLIN N, V16, P239
[9]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[10]   New classification and criteria for diagnosis of diabetes mellitus - Position statement from the Australian Diabetes Society, New Zealand Society for the Study of Diabetes, Royal College of Pathologists of Australasia and Australasian Association of Clinical Biochemists [J].
Colman, PG ;
Thomas, DW ;
Zimmet, PZ ;
Welborn, TA ;
Garcia-Webb, P ;
Moore, MP .
MEDICAL JOURNAL OF AUSTRALIA, 1999, 170 (08) :375-378